Nanomedicine applies nanoscale materials and methods to medical diagnosis and treatment, including drug delivery systems. It matters because controlling how therapies reach tissues can improve precision and help address barriers to effective treatment.
Antibody-drug conjugates are therapies that link an antibody to a drug payload to help deliver it to cells expressing a target.
Cold plasma uses low-temperature ionized gas to inactivate pathogens on surfaces, medical devices, or in healthcare environments.
Drug delivery systems are technologies and formulations designed to transport therapeutic substances to the body or a specific site in a controlled or targeted way.
Inhaled nanomedicines use nanoscale carriers or formulations to deliver therapeutic agents through the respiratory tract.
Inorganic nanoparticles are used as light-absorbing agents to generate heat for therapeutic treatment, often to destroy tumors.
Lipid nanoparticles are nanoscale lipid-based carriers used to protect and deliver messenger RNA into cells.
Polymeric micelles are nanoscale assemblies of amphiphilic polymers that form a core–shell structure in a liquid.
Stimuli-responsive drug delivery uses drug carriers or delivery systems that release therapeutic cargo in response to specific internal or external triggers.
Targeted exosome therapy uses exosomes or related extracellular vesicles to deliver therapeutic molecules to selected cells or tissues.
Targeted nanorobots are nanoscale robotic systems designed to navigate to or act at specific biological sites, such as tumors or other therapeutic targets.
Discover and track organizations, patents, publications, grants, news and more. Get live alerts on new startups, funding rounds and emerging developments.
This site uses cookies to ensure you get the best experience. You can manage our different cookies in the settings below. Cookies Policy